Sign In
Free Newsletter
Legal Elite 2024: Intellectual Property Law
Robert A. Angle Troutman Pepper Richmond Patrick C. Asplin Flora Pettit Charlottesville Timothy J. Bechen Woods Rogers Richmond Thomas F. Bergert Williams Mullen Charlottesville Duncan Byers Byers Law Williamsburg Janet W. Cho Williams Mullen Richmond Zachary D. Cohen ThompsonMcMullan Richmond Christopher M. Collins Vanderpool Frostick & Nishanian Manassas Andrew P. Connors Darkhorse Law Lynch[...]
Legal Elite 2023: Intellectual Property
Robert A. Angle Troutman Pepper, Richmond Patrick C. Asplin Flora Pettit, Charlottesville Timothy J. Bechen Woods Rogers Vandeventer Black, Richmond Thomas F. Bergert Williams Mullen, Charlottesville Duncan G. Byers Byers Law, Williamsburg Destinee Byers Davis Law Chesapeake Janet W. Cho Williams Mullen, Richmond Zachary D. Cohen ThompsonMcMullan, Richmond Christopher M. Collins Vanderpool Frost[...]
Altria can’t sell IQOS device in U.S. after ITC ruling stands
Henrico County-based Altria Group Inc. and former subsidiary New York-based Philip Morris International Inc. can no longer sell the IQOS tobacco heating device in the U.S. after the Biden administration’s 60-day administrative review process concluded Monday. On Sept. 29, the U.S. International Trade Commission determined that the IQOS device violated two of rival R.J. Reynolds […]
2021 INTELLECTUAL PROPERTY / INFORMATION TECHNOLOGY LAW Q&A
Peter J. Van Bergen Patent Attorney, Williamsburg Title: Owner Education: Bachelor’s degree, Bucknell University; law degree, William & Mary School of Law Spouse: Jamie Children: We raised our three great children (Elizabeth, Luke and John) in Williamsburg. Hobbies: Swimming, biking, running, kayaking, triathlon, reading Career mentors: David Blumenthal What is the biggest curren[...]
Richmond pharma company Kaléo acquired
New York-based Marathon Asset Management LP announced Monday it has entered into a definitive agreement to acquire Richmond-based privately held pharmaceutical company Kaléo Inc., which is known for making injectors to treat allergic anaphylaxis and opioids overdoses. The total base purchase price is approximately $310 million in cash, less certain adjustments and includes potential net […[...]
